In the National Pharmaceutical Pricing Authoritys notification SO 2293E, dated 10th July 2020 relating to fixation of retail price

This document is an addendum to the National Pharmaceutical Pricing Authority's (NPPA) notification S.O. 2293(E), dated July 10, 2020, concerning the fixation of retail prices for scheduled formulations. Published in the Gazette of India, Extraordinary, on July 23, 2020, this addendum modifies entries at Sl. No. 6 and 7 of the original notification's table, specifically within both the Hindi and English versions. The correction pertains to the ingredient listed for Norethisterone Acetate tablets manufactured and marketed by Ms. Zydus Healthcare Limited. The corrected entries are as follows: * **Sl. No. 6:** Norethisterone controlled-release tablet, where each film-coated tablet contains Norethisterone IP 10mg, marketed by Ms. Zydus Healthcare Limited, has a retail price of Rs. 15.40 per tablet. * **Sl. No. 7:** Norethisterone controlled-release tablet, where each film-coated tablet contains Norethisterone IP 15mg, marketed by Ms. Zydus Healthcare Limited, has a retail price of Rs. 17.83 per tablet. All other notes and contents from the original order S.O. 2293(E) dated July 10, 2020, remain unchanged. This addendum is issued by the Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers. The reference number for this notification is F. No. 8762020/D.P.NPPA-Div.II. The issuing officer is Prasanjit Das, Assistant Director.

Key Entities Referenced